Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart valve study aims to cut bleeding risk with routine drug use

NCT ID NCT05774691

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 29 times

Summary

This study compares giving a drug called protamine routinely after a minimally invasive heart valve replacement (TAVI) versus only giving it when needed. The goal is to see if routine use lowers the chance of death or serious bleeding within 30 days. About 1000 adults with aortic valve stenosis will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • A.S.Z. Aalst

    RECRUITING

    Aalst, Belgium

    Contact

  • Amsterdam University Medical Center

    NOT_YET_RECRUITING

    Amsterdam, Netherlands

    Contact

  • Leiden University Medical Center

    RECRUITING

    Leiden, South Holland, Netherlands

    Contact

    Contact

  • Maastricht UMC

    NOT_YET_RECRUITING

    Maastricht, Limburg, Netherlands

    Contact

  • St. Antonius Hospital

    RECRUITING

    Nieuwegein, Utrecht, Netherlands

    Contact

  • University Hospitals Leuven

    RECRUITING

    Leuven, Belgium

    Contact

Conditions

Explore the condition pages connected to this study.